Maynard Um
-
-
-
-
-
-
-
Kura Oncology (KURA) Reiterated at Overweight by Cantor Fitzgerald
-
-
-
-
-
-
-
Kura Oncology (KURA) Reports In-Line Q1 EPS
-
-
-
-
-
-
-
Kura Oncology (KURA) Reiterated at Market Outperform by Citizens on 2026 Outlook
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)
-
-
-
-
-
-
-
Kura Oncology (KURA) Shares Could Go Higher After AML Drug Approval Says Citizens
-
-
-
-
-
-
-
Citizens JMP Reiterates Market Outperform Rating on Kura Oncology (KURA)
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Kura Oncology (KURA)
-
443,852 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

